MedPath

Rare sugar in the patient with autism

Phase 1
Recruiting
Conditions
Impairments in social and language skills.Obesty
Registration Number
JPRN-jRCTs031180411
Lead Sponsor
Monden Yukifumi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
30
Inclusion Criteria

1. The diagnosis for ASD was made based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
2. Parents or legal guardians of the participant provide written informed consent for participation.

Exclusion Criteria

1. Comorbid severe neurodegenerative, metabolic, and progressive disorder
2. Severe abnormalities of blood or electrocardiogram examination
3. Persistent diarrhea
4. Severe drug or food allergy
5. Those who changed one's medicine related to symptoms of ASD, treatment of liver dysfunction or cholesterolemia within three months
6. Responsible doctors judged a patient inappropriate for the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse event: condition or frequency of stool, blood examination, weight loss, hypertension, fatigue, anxiety, dizziness, headache, edema.
Secondary Outcome Measures
NameTimeMethod
Autistic symptom (DSM-5, PARS, CARS2, Sensory Profile, SCQ, SRS2), autistic associated symptom (ABC-J, RBS-R, Vineland2), circadian rhythm, endocrine and metabolic examination (oxytocin, GLP-1), brain function (eye tracker, etc), developmental or intellectual evaluation (WISC-IV, etc)
© Copyright 2025. All Rights Reserved by MedPath